# Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)

> **NCT00002031** · NA · COMPLETED · sponsor: **University of California, San Francisco**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Dinitrochlorobenzene

## Key facts

- **NCT ID:** NCT00002031
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002031, "Evaluation of the Epidermal Langerhans Cell Population in AIDS / ARC Patients by the Topical Application of a Potent Contact Allergen (1-Chloro-2,4-Dinitro-Chlorobenzene) (DNCB)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00002031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*